Literature DB >> 15848580

Mycobacterial infections after kidney transplant.

T Jie1, A J Matas, K J Gillingham, D E R Sutherland, D L Dunn, A Humar.   

Abstract

We looked at mycobacterial infections occurring after a kidney transplant to determine incidence, risk factors, and outcomes. Of 3921 kidney transplants performed between 1984 and 2002, 18 (0.45%) (10 men, eight women; 11 cadaveric donor, seven living donor graft) were identified as having mycobacterial infection at some time posttransplant. Mean age at transplant was 38.3 years. Racial background was: Caucasian (n = 12), African-American (n = 2), Native Indian (n = 2), Hispanic (n = 1), and Middle Eastern (n = 1). The majority had a kidney alone (n = 14). Four recipients had simultaneous transplant of a second organ: pancreas (n = 2), islets (n = 1), and liver (n = 1). None of the 18 recipients had documented mycobacterial infection pretransplant. One recipient had a positive Mantoux test at the time of transplant and then developed pulmonary tuberculosis 4 months posttransplant; the remaining 17 patients had either negative (n = 10) or unavailable (n = 7) pretransplant Mantoux results. Mean time to infection was 3.2 years (range 1 week to 12 years). The most common site of infection was respiratory (n = 8). Other sites included musculoskeletal (n = 4), skin (n = 3), gyn (n = 1), and other (n = 2). Only three of the infections were with mycobacterial tuberculi; the others were with avium (n = 5), chelonae (n = 2), or other nontuberculous mycobacteria. Risk factors included previous TB exposure, occupational exposure, or accidental soft tissue injury. Soft tissue infections often presented as chronic unhealed wounds and required extensive surgical debridements. With mean follow-up of 12.5 years since transplant and 9.2 years since infection, 13 of the recipients are alive and well; causes of death included cardiovascular (n = 3) and sepsis (n = 2).

Entities:  

Mesh:

Year:  2005        PMID: 15848580     DOI: 10.1016/j.transproceed.2004.12.167

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

2.  Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients.

Authors:  B M Knoll
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

Review 3.  [Nontuberculous mycobacterial infections].

Authors:  A Nowag; M Platten; G Plum; P Hartmann
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

4.  Incidence and management of mycobacterial infection in solid organ transplant recipients.

Authors:  Ming-Hui Fan; Denis Hadjiliadis
Journal:  Curr Infect Dis Rep       Date:  2009-05       Impact factor: 3.725

Review 5.  Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update.

Authors:  Cybele L Abad; Raymund R Razonable
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-04-27

6.  Unusual Presentation of Disseminated Mycobacterium kansasii Infection in Renal Transplant Recipients and Rapid Diagnosis Using Plasma Microbial Cell-free DNA Next-generation Sequencing.

Authors:  Tosin Ogunsiakan; Kristen D Fajgenbaum; Thomas B Montgomery; Gautam M Phadke; Kiran Gajurel
Journal:  Transplant Direct       Date:  2022-02-21

7.  Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City.

Authors:  Ethan E Bodle; Jennifer A Cunningham; Phyllis Della-Latta; Neil W Schluger; Lisa Saiman
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.